<DOC>
	<DOC>NCT00381732</DOC>
	<brief_summary>This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of 2.5mg and 5mg tadalafil taken once daily in men with erectile dysfunction.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Men with erectile dysfunction At least 18 years of age Certain chronic medical conditions including cardiac disease, congestive heart failure, kidney or liver disease, cancer and HIV A history of certain impotence disorders History of specified pelvic surgery Any significant genital abnormality identified at the start of the study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Impotence</keyword>
	<keyword>erectile dysfunction</keyword>
</DOC>